Mostrar el registro sencillo

dc.contributor.authorVázquez Bourgon, Javier es_ES
dc.contributor.authorRodríguez-Rodríguez, Pabloes_ES
dc.contributor.authorGómez Ruiz, Elsaes_ES
dc.contributor.authorArtal Simón, Jesús Ángel es_ES
dc.contributor.authorCrespo Facorro, Benedicto es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2026-01-27T09:33:37Z
dc.date.available2026-01-27T09:33:37Z
dc.date.issued2014-11es_ES
dc.identifier.issn1547-3325es_ES
dc.identifier.issn1040-1237es_ES
dc.identifier.urihttps://hdl.handle.net/10902/38902
dc.description.abstractObsessive-compulsive symptoms (OCS) are common among patients with schizophrenia, with prevalence rates up to 30.3%.1 Although the pathophysiology underlying the presence of OCS in schizophrenia is unknown, it has been suggested their appearance may be a complication of secondgeneration antipsychotics, mainly because of these drugs' combined antagonistic action on D2 and 5-HT2 receptors. We report on a patient with psychosis who developed OCS when treated with paliperidone longacting depot injection.es_ES
dc.format.extent2 p.es_ES
dc.language.isoenges_ES
dc.publisherTaylor & Francises_ES
dc.rightsAlojado según Resolución CNEAI 10/12/25 (ANECA)es_ES
dc.sourceAnnals of Clinical Psychiatry, 2014, 26(4), 301-302es_ES
dc.titleObsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: a case reportes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsclosedAccesses_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo